Robert Goldenberg
Executive Director
pharmaceutical
Youdim Pharmaceuticals
Israel
Biography
Both molecules have been approved for therapy for unrelated indications, allowing BT a substantial acceleration of regulatory approvals.
Research Interest
Pharmaceutical science
